Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996 - Wikidata - awgldk - TriplyDB

Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996

Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996

http://www.wikidata.org/entity/Q58436602

about

Explaining the geographical variation of HIV among injection drug users in the United States Use of the "NYC Condom" among people who use drugs.Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study Network Firewall Dynamics and the Subsaturation Stabilization of HIV.Interpreting the relation between injection drug use and harm: a cautionary note.A stochastic agent-based model of pathogen propagation in dynamic multi-relational social networks.HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.A perfect storm: crack cocaine, HSV-2, and HIV among non-injecting drug users in New York City.Risks for HIV infection among users and sellers of crack, powder cocaine and heroin in central Harlem: implications for interventions Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for "Ending the Epidemic"What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey Preventing HIV in injection drug users: choosing the best mix of interventions for the population.Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area HIV among injection drug users in large US metropolitan areas, 1998 Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users.Trends in the AIDS epidemic among New York City's injection drug users: localized or citywide?Expanded syringe access demonstration program in New York State: an intervention to prevent HIV/AIDS transmission.Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population.Continuing HIV risk in New York City injection drug users: the association of syringe source and syringe sharing.Harm reduction interventions in HIV care: a qualitative exploration of patient and provider perspectives.Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009 HIV prevalence rates among injection drug users in 96 large US metropolitan areas, 1992-2002.Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.Large sharing networks and unusual injection practices explain the rapid rise in HIV among IDUs in Sargodha, Pakistan Combined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York City.A reexamination of connectivity trends via exponential random graph modeling in two IDU risk networks What happened to the HIV epidemic among non-injecting drug users in New York City?Hepatitis C incidence--a comparison between injection and noninjection drug users in New York City.The Interaction of Risk Network Structures and Virus Natural History in the Non-spreading of HIV Among People Who Inject Drugs in the Early Stages of the Epidemic.Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV

P2860

Q24537299-1CE41ECD-E88B-4EE7-B125-9B5C8FFDCDA9 Q33818262-73D1632C-F764-46F3-9159-FBFED51E4FBB Q33833339-681024C2-4CCA-4B01-9031-6F33438B1BB4 Q33966080-6FF1F9A4-59B7-4335-906D-29C7B0486989 Q34037977-84056291-9D29-4477-81AC-D343BB57849C Q35292072-6435EF65-6938-48CD-96F9-0185E833DEF7 Q35659939-E3988068-68E1-4B0B-94E1-5DE93358B255 Q35671191-227CA1E8-E6F9-4D45-B183-9D6439AF275F Q35944281-43116540-B8D2-4AED-B3C2-868DDE6653CA Q36025521-29F7C90B-CA6E-4DD7-A44B-B52D1847A739 Q36272095-B26BA80F-938D-4D4C-81E6-5DA884CBBE40 Q36272465-48A819AC-7226-4E40-9BB5-E266CBBFDB46 Q36272739-F3AC3818-5856-4D9A-BCB6-1B1C027018EA Q36272762-48379660-450B-4EAE-86FB-39E7D3517BED Q36273875-45BE645C-3C43-4DE6-ABFB-41ED50298190 Q36273958-0D1A977E-23A1-43F4-A9B2-7F8DB38406F1 Q36274867-2DBB2DF3-4C3A-453F-BE1F-317DB390AF48 Q36440656-C3C1FC21-24CD-4560-A811-98D2B54246E3 Q36701912-BDF1E8AD-30C4-45DB-9D03-6C9A40559C64 Q36826390-525CF788-C2AF-4174-9D7D-B5FC781DC487 Q37040594-674BB684-4C32-4961-885C-CE7506B0D6C2 Q37069196-480C9F02-3DCF-40AB-97A2-CADE36302BC9 Q37237728-A002E240-3359-4DE6-BEF0-A6A4BC6860FC Q37268417-35798603-94D3-4654-9DA5-10B10CD18AAB Q37626445-6C7D217D-B8FC-4CB1-89F1-EA1F2EEF0CB7 Q37660585-434044B1-B280-4579-8AE6-9E6F065EF688 Q38405732-C9BB152A-E904-4CB0-9489-0BB85B9AF5DC Q39679908-DA9586A4-1DC0-4768-A722-52652B9290CF Q40517781-92145F59-923F-4A84-B752-0197F9463541 Q52622035-B76A3E22-5F73-49CC-B76B-2D2200E67041 Q55442132-05E4FE76-6B69-4F02-89D6-9D934560F81C Q56961744-4E76E05F-07F8-4B07-8CC2-4A55082355BD

P2860

Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996

http://www.wikidata.org/entity/Q58436602

description

im Dezember 1998 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 1998

@uk

name

Declining seroprevalence in a ...... in New York City, 1991 to 1996

@en

Declining seroprevalence in a ...... in New York City, 1991 to 1996

@nl

type

label

Declining seroprevalence in a ...... in New York City, 1991 to 1996

@en

Declining seroprevalence in a ...... in New York City, 1991 to 1996

@nl

prefLabel

Declining seroprevalence in a ...... in New York City, 1991 to 1996

@en

Declining seroprevalence in a ...... in New York City, 1991 to 1996

@nl

P1433

Q58436602-9D040B08-EEFB-4992-9E18-5A0B2ADA5D1D

P1476

Q58436602-93AB8C79-6176-4568-AC28-EA3E274EB040

P2093

Q58436602-0A61A9C0-8C06-42DD-B9FE-F86A5D6C93AA

Q58436602-370E667A-FAAB-49C7-B030-D413CED59E33

Q58436602-4219E482-E9AF-459B-A743-FB125387D0D9

Q58436602-59662560-A1DC-4FC7-B196-883E678E916E

Q58436602-70E4A896-4C27-44F1-A09D-A31F96E0B890

Q58436602-857F5F50-8BA6-44CF-81C5-234D93B212E9

Q58436602-A123FAB6-4A61-4B29-B03D-5168063240D9

Q58436602-A360128C-DDDD-4AE1-9901-9CBA7A6ED1FA

Q58436602-AD79FE29-9903-4BA5-B512-F0B8A14F42F3

Q58436602-C476C6F4-6965-4C29-9DA4-383A16FA9E72

P2860

Q58436602-1576A430-7C5F-4943-A867-2B377614CAED

Q58436602-40E84F96-6752-48A0-B8C7-E2B443800EF8

Q58436602-49F8299D-A78C-4CE4-B867-AB6B68450942

Q58436602-59F4DB4B-5915-4D53-AE85-739ADA904E68

Q58436602-7CC19A7C-096B-4475-A147-B067A5D82CAB

Q58436602-829B1CB3-F3D6-4BA1-80E6-C92315033ACF

Q58436602-B448792D-0216-4A24-9C2C-81B67337A233

Q58436602-D3675C27-FDE9-479E-8AE0-3581B5D2A6F2

Q58436602-D4922FA6-5DD9-4434-894A-208F786434C7

Q58436602-EF5EDEB5-D917-4813-96A7-3ECEF816EE82

P304

Q58436602-032895D0-27F5-452A-BB1C-E874BF20934D

P31

Q58436602-A640C97C-038A-4703-A5AE-9F8196952853

P407

Q58436602-7FB33F1A-6D8A-4F0A-AB25-75468565C3A1

P433

Q58436602-A911E2F4-09BC-4DDD-8AAC-9AB9E851E34E

P478

Q58436602-61F25676-B33E-4532-AB67-8F1448CF8CAE

P577

Q58436602-0DB2B870-8A7A-404D-A4CD-784403B69169

P698

Q58436602-6FEB2C2A-6FDE-4BE1-B272-3687658976D4

P921

Q58436602-1A126895-26DB-47A2-A9A8-F986D12D8DD8

P932

Q58436602-87EB02EE-1348-4ACA-BAA3-1928F16F418D

P1433

American Journal of Public Health

P1476

Declining seroprevalence in a ...... in New York City, 1991 to 1996

@en

P2093

D C Des Jarlais

http://www.w3.org/2001/XMLSchema#string

D Paone

http://www.w3.org/2001/XMLSchema#string

E DeBernardo

http://www.w3.org/2001/XMLSchema#string

E Monterroso

http://www.w3.org/2001/XMLSchema#string

J L Sotheran

http://www.w3.org/2001/XMLSchema#string

L V Torian

http://www.w3.org/2001/XMLSchema#string

M Beardsley

http://www.w3.org/2001/XMLSchema#string

M Marmor

http://www.w3.org/2001/XMLSchema#string

S Deren

http://www.w3.org/2001/XMLSchema#string

S R Friedman

http://www.w3.org/2001/XMLSchema#string

P2860

HIV incidence among injecting drug users in New York City syringe-exchange programmes.

Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.

Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.

Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City.

Needle exchange use among a cohort of injecting drug users.

Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals.

Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988-1993.

Weight loss associated with HIV seroconversion among injection-drug users.

Opiate dependency among the subscribers of a New York area private insurance plan.

Exposure factors for HIV-1 infection among heterosexual drug abusers in New Jersey treatment programs.

P304

1801-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

1998-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9842377

http://www.w3.org/2001/XMLSchema#string

P921

P932

1509056

http://www.w3.org/2001/XMLSchema#string